Trial: 201704081

A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Phase

III (Cancer Control)

Principal Investigator

Picus, Joel

Disease Site

Prostate

Learn more about this study at: clinicaltrials.gov